News » Archives » September 2015

Holly Weiss-Bilka, a postdoctoral associate in the Department of Biological Sciences, was awarded ‘best poster presentation’ in the postdoctoral division at the 2015 Indiana Clinical and Translational Sciences Institute (CTSI) annual meeting. As part of the award, Weiss-Bilka will receive $1,000 in research supply funds from the Indiana CTSI.

SUBMISSION DEADLINE – THURSDAY, OCTOBER…

Head and neck squamous cell carcinoma (HNSCC) is the sixth most prevalent cancer worldwide. Although the overall incidence of HNSCC has decreased over the years due to public health efforts to promote smoking cessation, the incidence of oropharyngeal (tonsillar area) squamous cell carcinoma (OPSCC), which is associated with human papillomavirus (HPV), has increased over 200% from 1984-2004.

Watch video

Mary Galvin, the William K. Warren Foundation Dean of the College of Science, sat down for a brief question-and-answer session about her experience, her passion for scientific research and her new role at the University of Notre Dame.

When asked what drew her to Notre Dame, Galvin is quick to answer: alignment with the University’s mission, and the chance to work with students again.

For a third consecutive year, the University of Notre Dame’s Advanced Diagnostics & Therapeutics (AD&T) initiative announced grant awards for a range of research projects that have the potential to solve significant problems in human and environmental health. The awards foster interdisciplinary research and promote new commercialization activity. Technologies developed through previous grants have been licensed by start-up companies, such as Contect and Enlightened Diagnostics, and spurred collaboration with external partners, including the Indiana University School of Medicine-South Bend, Saint Mary’s College, and Central Michigan University. This year’s projects show similar promise, and for the first time one was selected for joint funding by both AD&T and Notre Dame’s Harper Cancer Research Institute (HCRI).

Drug…

With ovarian cancer ranking fifth in cancer deaths among women, there is an urgent need to increase research to improve early

…

Professor Marya Lieberman has been awarded a grant from the US Agency for International Development (USAID) to monitor the quality of pharmaceuticals across western Kenya through the use of innovative diagnostic test cards developed in her laboratory. These inexpensive, point-of-need devices have been shown to detect falsified antibiotics, TB medications, and anti-malarial drugs. 

On Wednesday, September 16th, 2015, Notre Dame Research will host its annual Core Facility Fair from 10:00 a.m. to 2:00 p.m. in the Jordan Hall of Science Galleria.